Applicant, as named in the Orange Book

Mayne Pharma

Next listed expiry: Sorilux on 7 May 2028. 11 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Sorilux calcipotriene	calcipotriene	022563	7 May 2028	patent
Fabior tazarotene	tazarotene	202428	24 Feb 2030	patent
Bijuva · 2 strengths estradiol; progesterone	estradiol; progesterone	210132	21 Nov 2032	patent
Tolsura itraconazole	itraconazole	208901	21 Jun 2033	patent
Imvexxy · 2 strengths estradiol	estradiol	208564	2 Feb 2034	patent, carve-out possible
Doryx Mpc doxycycline hyclate	doxycycline hyclate	050795	23 Dec 2034	patent
Rhofade oxymetazoline hydrochloride	oxymetazoline hydrochloride	208552	11 Jun 2035	patent, carve-out possible
Annovera ethinyl estradiol; segesterone acetate	ethinyl estradiol; segesterone acetate	209627	21 Jun 2039	patent
Epsolay benzoyl peroxide	benzoyl peroxide	214510	23 May 2041	patent
Twyneo benzoyl peroxide; tretinoin	benzoyl peroxide; tretinoin	214902	23 May 2041	patent
Nextstellis drospirenone; estetrol	drospirenone; estetrol	214154	1 Oct 2043	patent, carve-out possible